Autolus Therapeutics (AUTL) Cash from Operations Growth (5y) (2022 - 2025)
Autolus Therapeutics (AUTL) Cash from Operations Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | 392.55 Mn | 91.84 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.41% |
| Sep 30, 2025 | -11.69% |
| Jun 30, 2025 | -22.00% |
| Mar 31, 2025 | -25.75% |
| Jun 30, 2024 | -3.16% |
| Mar 31, 2024 | -8.85% |
| Dec 31, 2023 | -22.08% |
| Sep 30, 2023 | -4.97% |
| Jun 30, 2023 | -21.56% |
| Dec 31, 2022 | -10.61% |